Agenus (AGEN) Change in Accured Expenses (2010 - 2026)
Agenus (AGEN) posted quarterly Change in Accured Expenses of -$3.1 million for Q1 2026, down 323.35% year-over-year from $1.4 million in Q1 2025, and up 65.53% quarter-over-quarter from -$8.9 million in Q4 2025.
Analysis
Agenus (AGEN) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Agenus' Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$3.1 million for Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 323.35% year-over-year to -$3.1 million; the TTM figure through Mar 2026 stood at $40000.0 (down 99.22% YoY), while the FY2025 annual figure was $4.5 million, up 3208.09% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$3.1 million, up from -$8.9 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $9.2 million in Q3 2025, with the low at -$8.9 million in Q4 2025.
- The 5-year median for Change in Accured Expenses is $2.1 million (2024), against an average of $1.4 million.
- The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses surged 1748.75% in 2023, then slumped 463.43% in 2025.
- Agenus' Change in Accured Expenses stood at $4.6 million in 2022, then soared by 77.6% to $8.1 million in 2023, then sank by 119.59% to -$1.6 million in 2024, then plunged by 463.43% to -$8.9 million in 2025, then surged by 65.53% to -$3.1 million in 2026.
- Business Quant data shows AGEN's Change in Accured Expenses at -$3.1 million in Q1 2026, -$8.9 million in Q4 2025, and $9.2 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.74 Bn | 130.89 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.52 Bn | 77.52 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.04 Bn | 52.91 Bn | 52.00 Mn | 11.00 Mn |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - | 55.78 Mn |
| 6 | BeOne Medicines | 39.98 Bn | 34.88 Bn | 1.53 Bn | 212.44 Mn |
| 7 | Alnylam Pharmaceuticals | 35.46 Bn | 32.15 Bn | 992.69 Mn | 61.62 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 68.82 Mn |
| 10 | Agenus | 339.80 Mn | 339.80 Mn | 34.52 Mn | 202,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 202,000.00 |
| Mar 31, 2026 | -3.08 Mn |
| Dec 31, 2025 | -8.94 Mn |
| Sep 30, 2025 | 9.21 Mn |
| Jun 30, 2025 | 2.85 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | -1.59 Mn |
| Sep 30, 2024 | 2.11 Mn |
| Jun 30, 2024 | 3.24 Mn |
| Mar 31, 2024 | -3.62 Mn |
| Dec 31, 2023 | 8.10 Mn |
| Sep 30, 2023 | 4.38 Mn |
| Jun 30, 2023 | 2.98 Mn |
| Mar 31, 2023 | 5.16 Mn |
| Dec 31, 2022 | 4.56 Mn |
| Sep 30, 2022 | -971,000.00 |
| Jun 30, 2022 | -1.83 Mn |
| Mar 31, 2022 | 279,000.00 |
| Dec 31, 2021 | 10.12 Mn |
| Sep 30, 2021 | -14.68 Mn |